INVO Fertility (IVF) Return on Equity (2011 - 2025)

INVO Fertility (IVF) has 15 years of Return on Equity data on file, last reported at 0.05% in Q3 2025.

• Quarterly Return on Equity rose 6.0% year-over-year to 0.05% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.05% (up 6.0% YoY) and the FY2024 annual result came in at 0.01%, down 191.0% from the prior year.
• Return on Equity grew to 0.05% in Q3 2025 per IVF's latest filing, from 0.08% in the prior quarter.
• Across five years, Return on Equity topped out at 0.24% in Q1 2023 and bottomed at 0.7% in Q4 2022.
• The 5-year median for Return on Equity is 0.03% (2025), against an average of 0.05%.
• The widest annual swing landed in 2022, when Return on Equity tumbled 69 bps; it then surged 57 bps in 2023.
• Tracing IVF's Return on Equity over 5 years: stood at 0.01% in 2021, then slumped by 4980 bps to 0.7% in 2022, then jumped by 82 bps to 0.13% in 2023, then surged by 89 bps to 0.01% in 2024, then sank by 256 bps to 0.05% in 2025.
• Per Business Quant, the three latest IVF Return on Equity figures stand at 0.05% (Q3 2025), 0.08% (Q2 2025), and 0.03% (Q1 2025).

Peer Comparison